Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Barbara Gayle Duncan Insider Profile
4 Followers
Barbara Gayle Duncan, CFO at Intercept Pharma, holds 24.89K shares in Intercept Pharma (Ticker: ICPT), holds ― shares in Adaptimmune Therapeutics (Ticker: ADAP), holds 9.25K shares in Halozyme (Ticker: HALO). Most recently, Barbara Gayle Duncan Sold ― shares of Intercept Pharma on Oct 05, 2016 for an estimated value of 23.99K.
Profitable Transactions
9 out of 10 Profitable Transactions
Average Return
+40.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Barbara Gayle Duncan's holdings
Insider Roles
Roles that Barbara Gayle Duncan holds in companies
Most Profitable Insider Trade
Stock:
Immunomedics
(IMMU)
(IMMU)
Rating:Informative Buy
Date:Aug 14, 2020 - Aug 14, 2021
Return:+119.60%
The most profitable trade made by Barbara Gayle Duncan
Barbara Gayle Duncan's Trading History
Intercept Pharma
Oct 05, 2016
CFO
Informative Sell
23.99K
$461.50K
Adaptimmune Therapeutics
―
Director
―
―
Innoviva
Apr 24, 2017
Director
Uninformative Buy
―
$0.00
Jounce Therapeutics
Sep 16, 2020
―
Uninformative Sell
100.00K
$0.00
Ovid Therapeutics
―
Director
―
―
Immunomedics
Oct 23, 2020
―
Uninformative Sell
―
$0.00
Atea Pharmaceuticals
―
Director
―
―
Fusion Pharmaceuticals
―
Director
―
―
Halozyme
May 09, 2023
Director
Uninformative Buy
―
$353.46K
Aevi Genomic Medicine
Oct 18, 2017
―
Informative Buy
75.00K
$0.00
List of latest transactions for each holding click on a transaction to see Barbara Gayle Duncan's performance on stock
You May Also Like
Barbara Gayle Duncan insider profile FAQ
What is the percentage of profitable transactions made by Barbara Gayle Duncan?
The percentage of profitable transactions made by Barbara Gayle Duncan is 90%.
What is the average return per transaction made by Barbara Gayle Duncan?
The average return per transaction made by Barbara Gayle Duncan is 40.70%.
What stocks does Barbara Gayle Duncan hold?
Barbara Gayle Duncan holds: ICPT, ADAP, INVA, JNCE, OVID, IMMU, AVIR, FUSN, HALO, GNMX stocks.
What was Barbara Gayle Duncan’s latest transaction?
Barbara Gayle Duncan latest transaction was an Informative Sell of $23.99K.
What was Barbara Gayle Duncan's most profitable transaction?
Barbara Gayle Duncan’s most profitable transaction was an Informative Buy of IMMU stock on August 14, 2020. The return on the trade was 119.60%.
What is Barbara Gayle Duncan's role in Intercept Pharma?
Barbara Gayle Duncan's role in Intercept Pharma is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.